These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12462167)

  • 1. Assessing risks--challenges posed by the European general product safety directive.
    van Aken D
    Inj Control Saf Promot; 2002 Sep; 9(3):151-6. PubMed ID: 12462167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product safety--are we managing the risk?
    O'Bryen G
    Inj Control Saf Promot; 2002 Sep; 9(3):157-9. PubMed ID: 12462168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk management by labelling 26 fragrances? Evaluation of Article 10 (1) of the seventh Amendment (Guideline 2003/15/EC) of the Cosmetic Directive.
    Klaschka U
    Int J Hyg Environ Health; 2010 Jul; 213(4):308-20. PubMed ID: 20451450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications.
    Wood M; Pichard A; Gundert-Remy U; de Rooij C; Tissot SM
    J Hazard Mater; 2006 May; 133(1-3):8-15. PubMed ID: 16343752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codex guidelines for GM foods include the analysis of unintended effects.
    Haslberger AG
    Nat Biotechnol; 2003 Jul; 21(7):739-41. PubMed ID: 12833088
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global view on ARAMIS, a risk assessment methodology for industries in the framework of the SEVESO II directive.
    Salvi O; Debray B
    J Hazard Mater; 2006 Mar; 130(3):187-99. PubMed ID: 16236437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in consumer exposure modeling: towards harmonization on a global scale.
    Kephalopoulos S; Bruinen de Bruin Y; Arvanitis A; Hakkinen P; Jantunen M
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S90-100. PubMed ID: 17668010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal aspects of E-HEALTH.
    Callens S; Cierkens K
    Stud Health Technol Inform; 2008; 141():47-56. PubMed ID: 18953124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of biological hazards in the European Union.
    Hugas M; Tsigarida E; Robinson T; Calistri P
    Int J Food Microbiol; 2007 Nov; 120(1-2):131-5. PubMed ID: 17659800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral safety in homoeopathic medicinal products.
    Schultz N; Franck-Karl G; Schilk J; Rose N
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing new European vigilance procedures.
    Donawa M
    Med Device Technol; 2007; 18(7):34, 36-7. PubMed ID: 18075133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How reasonable is reasonable use? The search for safer stepladders.
    Clift L; Navarro TB; Thomas DA
    Inj Control Saf Promot; 2002 Sep; 9(3):175-84. PubMed ID: 12462171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk assessment: a critical approach of the European TGD in an in situ application.
    Guérit I; Bocquené G; James A; Thybaud E; Minier C
    Ecotoxicol Environ Saf; 2008 Sep; 71(1):291-300. PubMed ID: 18378309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.